Physician profile
John W King
NPI 1730129800
$1,744.82
in general payments reported to CMS, 2019-2025
19 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $340 · 2020: $220 · 2021: $197 · 2022: $431 · 2023: $280 · 2024: $58.62 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $557.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $557.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $392.18 | 2019-2022 | |
| Ferring Pharmaceuticals INC. | $260.28 | 2019-2023 | Euflexxa |
| Fidia Pharma USA INC. | $168.48 | 2019-2023 | Triluron, Hymovis |
| Heron Therapeutics, INC. | $150.32 | 2022-2025 | Zynrelef |
| Depuy Synthes Sales INC. | $131.91 | 2019-2025 | Orthovisc |
| Boston Scientific Corporation | $115.93 | 2025 | Intracept Rf Probe |
| Becton, Dickinson and Company | $89.79 | 2023 | Arista Ah Flexitip |
| Ethicon US, LLC | $77.28 | 2023-2024 | Stratafix, Ethicon, Vistaseal |
| Daiichi Sankyo INC. | $70.47 | 2019-2020 | |
| Royal Biologics, INC. | $67.06 | 2022 | |
| Horizon Therapeutics Plc | $55.24 | 2019-2021 | |
| Smith+Nephew, INC. | $36.54 | 2019 | |
| Ermi LLC | $26.05 | 2019 | |
| Vericel Corporation | $21.37 | 2022 | |
| Seapearl East, INC | $20.41 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Next Science LLC | $18.99 | 2023 | Xperience, Surgx, Blastx |
| Zyla Life Sciences, INC. | $14.68 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $14.44 | 2023 | Seglentis |
| Sanofi-Aventis U.S. LLC | $13.40 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John King listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.